The recent instability in global distribution have highlighted the importance of securing critical medications like Ivermectin. Trusting on overseas producers exposes countries to potential vulnerabilities, including delivery delays, cost fluctuations, and even geopolitical concerns. Transitioning towards domestic production of Ivermectin offers a